SSRIs: suicide risk and withdrawal – (06-23-03)



SSRIs: suicide risk and withdrawal

Wow. GlaxoSmithkline withheld info from the UK’s regulatory agency when it got approval for paroxetine (Paxil). The study basically showed no increased efficacy over placebo. My question is…this kind of behavior is rampant here in the US as well. How on Earth do these companies not get shut down by the regulatory agencies? Unfortunately, I think we can all guess at the answer.

The Journal : Current Issue

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Miscellaneous
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”